Cationic bakuchiol-loaded lipid nanoparticles enhance skin permeation and modulate neuro-immune inflammation and itch pathways in atopic dermatitis
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bioactive natural compounds · Plant chemical constituents analysis · Alkaloids: synthesis and pharmacology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Depression and anxiety in patients with atopic dermatitis10.1016/j.anai.2025.02.017 ↗
2. The global, regional, and national burden of atopic dermatitis in 195 countries and territories: an ecological study from the global burden of disease study 2017
3. Epidermal barrier dysfunction in atopic dermatitis10.1038/jid.2009.133 ↗
4. TSLP impairs epidermal barrier integrity by stimulating the formation of nuclear IL-33/Phosphorylated STAT3 complex in human keratinocytes10.1016/j.jid.2022.01.005 ↗
5. Interleukin-31: the “itchy” cytokine in inflammation and therapy10.1111/all.14791 ↗
6. Glucocorticoid-induced skin atrophy: the old and the new10.2147/CCID.S224211 ↗
7. Glucocorticoid therapy and adrenal suppression10.2298/MPNS1712465B ↗
8. Biologics for treatment of atopic dermatitis: current status and future prospect10.1016/j.jaip.2020.11.034 ↗
9. Direct and indirect effects of crisaborole ointment on quality of life in patients with atopic dermatitis: a mediation analysis10.2340/00015555-3181 ↗
10. Inhibitory effects of bakuchiol, bavachin, and isobavachalcone isolated from piper longum on melanin production in b16 mouse melanoma cells10.1271/bbb.100221 ↗
11. Anti-allergic and anti-inflammatory effects of bakuchiol on ovalbumin-induced allergic rhinitis in mice10.1007/s12010-023-04675-8 ↗
12. Bakuchiol suppresses inflammatory responses via the downregulation of the p38 MAPK/ERK signaling pathway10.3390/ijms20143574 ↗
13. Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway10.1042/BSR20181043 ↗
14. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention10.1016/j.ijpharm.2021.121082 ↗
15. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization10.1016/j.vaccine.2012.12.048 ↗
16. Surface-charge-dependent nanoparticles accumulation in inflamed skin10.1002/jps.23282 ↗
17. Optimization of differentiation and transcriptomic profile of THP-1 cells into macrophage by PMA
18. Exogenous drug-induced mouse models of atopic dermatitis10.1016/j.cytogfr.2024.01.003 ↗
19. Effect of charge carrier lipid on skin penetration, retention, and hair growth of topically applied finasteride-containing liposomes10.4062/biomolther.2011.19.2.231 ↗
20. Effects of surface charge and flexibility of liposomes on dermal drug delivery
21. Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery10.2147/IJN.S150086 ↗
22. Exploring the potential of minoxidil tretinoin liposomal based hydrogel for topical delivery in the treatment of androgenic alopecia10.1080/15569527.2019.1694032 ↗
23. Transdermal delivery of mixnoxidil with block copolymer nanoparticles10.1016/S0168-3659(04)00167-1 ↗
24. Strat-M® synthetic membrane: permeability comparison to human cadaver skin10.1016/j.ijpharm.2018.06.012 ↗
25. Physical properties of gold nanoparticles affect skin penetration via hair follicles
26. Activating THP1-derived macrophage in vitro
27. FFA2 activation ameliorates 2,4-Dinitrochlorobenzene-Induced atopic dermatitis in mice10.4062/biomolther.2019.160 ↗
28. Caffeoyl–pro–his amide relieve DNCB-induced atopic dermatitis-like phenotypes in BALB/c mice10.1038/s41598-020-65502-2 ↗
29. Deacetylasperulosidic acid ameliorates pruritus, immune imbalance, and skin barrier dysfunction in 2,4-dinitrochlorobenzene-induced atopic dermatitis nc/nga mice
30. Peripheral itch sensitization in atopic dermatitis10.1016/j.alit.2022.04.003 ↗
31. The itch–scratch cycle: a neuroimmune perspective10.1016/j.it.2018.10.001 ↗
32. Filaggrin in the frontline: role in skin barrier function and disease10.1242/jcs.033969 ↗
33. Loricrin - an overview10.4103/0973-029X.157204 ↗
34. Claudin-1 decrease impacts epidermal barrier function in atopic dermatitis lesions dose-dependently10.1038/s41598-020-58718-9 ↗
35. Improvement of post-inflammatory hyperpigmentation, subsequent to cold atmospheric plasma treatment, in a patient with atopic dermatitis10.25289/ML.2020.9.2.187 ↗
36. Chaetocin inhibits IBMX-induced melanogenesis in B16F10 mouse melanoma cells through activation of ERK10.1016/j.cbi.2015.12.021 ↗